PAMU
ABMD

Pictet Asset Management (UK)’s Abiomed Inc ABMD Stock Holding History

Pictet Asset Management (UK)’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$7.06M Buy
22,630
+720
+3% +$221K 0.01% 774
2021
Q1 		$6.98M Sell
21,910
-2,350
-10% -$752K 0.01% 754
2020
Q4 		$7.87M Buy
24,260
+2,250
+10% +$622K 0.01% 704
2020
Q3 		$6.1M Sell
22,010
-610
-3% -$176K 0.01% 673
2020
Q2 		$5.46M Buy
22,620
+320
+1% +$64.3K 0.01% 660
2020
Q1 		$3.24M Buy
22,300
+2,380
+12% +$395K 0.01% 753
2019
Q4 		$3.4M Sell
19,920
-120
-0.6% -$22.2K 0.01% 843
2019
Q3 		$3.56M Sell
20,040
-830
-4% -$179K 0.01% 775
2019
Q2 		$5.44M Sell
20,870
-70
-0.3% -$18.6K 0.01% 680
2019
Q1 		$5.98M Buy
20,940
+140
+0.7% +$46.5K 0.01% 662
2018
Q4 		$6.76K Sell
20,800
-140
-0.7% -$48.6K 0.02% 585
2018
Q3 		$9.42M Sell
20,940
-960
-4% -$378K 0.02% 585
2018
Q2 		$8.96M Buy
+21,900
New +$7.93M 0.02% 532

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Pictet Asset Management (UK)'s ABMD Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Abiomed Inc (ABMD) stake by 3.3% in Q2 2021, buying an estimated $221K and bringing the position to 22,630 shares worth $7.06M. The position accounts for 0.01% of the portfolio, ranked #774.

Pictet Asset Management (UK) first reported a position in ABMD in Q2 2018 and has held it in 13 quarters since. The position peaked at $9.42M in Q3 2018. 474 funds tracked by Wall St. Rank hold ABMD as of Q2 2021.

  • Pictet Asset Management (UK) held 22,630 shares of Abiomed Inc worth $7.06M as of Q2 2021.
  • Pictet Asset Management (UK) bought 720 Abiomed Inc shares in Q2 2021, an estimated $221K.
  • Abiomed Inc made up 0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #774 holding.
  • Pictet Asset Management (UK) first reported a position in Abiomed Inc in Q2 2018 and has held it in 13 quarters since.
  • Pictet Asset Management (UK)'s Abiomed Inc position peaked at $9.42M in Q3 2018.
  • 474 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.